Potential Dilution from the Exercise of Stock Acquisition Rights
First written in FY2024. 2 of 6 entries say "Materialised", first in FY2026-H1. Latest entry: FY2026.
The whole theme swung hardest in 2018: 9 of 9 companies on the "Worse" side.
0 other companies' latest entry also says "Raised".
- FY2026RaisedAnnual report
「In June 2026, we issued 2,098,000 common shares and 37,970 Series 7 stock acquisition rights through a third-party allotment to Cybridge LLC. The number of shares underlying these rights is 3,797,000, and」
In addition to prior exercises, the third-party allotment created substantial potential dilution, including up to 3,797,000 shares, increasing the dilution risk. - FY2026-H1MaterialisedAnnual report
「Increase in total issued shares: 150,960 shares; increase in stated capital: ¥27,564 thousand; increase in capital surplus: ¥27,564 thousand. (Note) These increases resulted from the exercise of stock acquisition rights.」
Exercise of stock acquisition rights resulted in the issuance of 150,960 shares and increases of ¥27,564 thousand in both stated capital and capital surplus, making the dilution risk a realized event. - FY2025MitigatedAnnual report
「We have granted officers and employees of our group stock acquisition rights over 1,201,940 shares, equivalent to 10.49% of total shares, as an incentive to enhance corporate value over the long term.」
Potential shares and the ratio declined from 1,354,000 shares and 11.82% in FY2024, but the company continues to consider additional grants and the dilution risk remains. - FY2024First statedAnnual report
「We have granted officers and employees stock acquisition rights over 1,354,000 shares, equivalent to 11.82% of total shares, as an incentive to enhance corporate value over the long term.」
The company is considering further stock-option grants to secure capable personnel and improve motivation, and identifies dilution upon exercise as a risk.